Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T11:48:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T12:34:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:19:42.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The SWIPE study page now presents a 403 error page, replacing the previously visible trial details and identifiers with a generic error screen, effectively hiding the study information from the public view.
    Difference
    18%
    Check dated 2026-09-20T20:29:26.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears, replacing the previous v3.6.5 to indicate an updated page version; this reflects a maintenance/update to the page's metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-30T17:37:37.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The page's revision tag has been updated to v3.6.5, replacing the previous v3.6.4, indicating a small editorial or system update to the study page.
    Difference
    0.1%
    Check dated 2026-08-09T08:43:17.000Z thumbnail image

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.